FDA Grants Breakthrough Designation for Quest’s Adeno-Associated Virus Test
Quest Diagnostics announced that its AAVrh74 ELISA assay (CDx) has been granted Breakthrough Device Designation from the U.S. FDA.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
